chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Tremor
Clinical narrative: shakiness; achiness; chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shakiness), MYALGIA (achiness) and CHILLS (chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 063B21A and 006B21A) for COVID-19 vaccination.     no medical history provided by the reporter.  Concomitant products included TRAZODONE, ALPRAZOLAM (XANAX) and VITAMIN D3 for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced TREMOR (shakiness), MYALGIA (achiness) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at a dose of 1 UNK. At the time of the report, TREMOR (shakiness), MYALGIA (achiness) and CHILLS (chills) outcome was unknown. Not Provided
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing in ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in ears) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (ringing in ears). At the time of the report, TINNITUS (ringing in ears) outcome was unknown. Not Provided          No concomitant was provided. Patient treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Myalgia, Neck pain
Clinical narrative: pain in her neck; having pain in both arms,body aches is normal post vaccination; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), NECK PAIN (pain in her neck) and MYALGIA (having pain in both arms,body aches is normal post vaccination) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 13-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and MYALGIA (having pain in both arms,body aches is normal post vaccination). On an unknown date, the patient experienced NECK PAIN (pain in her neck). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), NECK PAIN (pain in her neck) and MYALGIA (having pain in both arms,body aches is normal post vaccination) outcome was unknown.            No concomitant was reported.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dyspnoea, Fatigue, Muscle spasms, Myocardial infarction
Clinical narrative: He thought it was an onset of heart attack; Severe muscle spasms size of walnut knot by the shoulder and injection site; Back pain; couldn't breath and feels like squeezing; extreme pain; tired; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (He thought it was an onset of heart attack), MUSCLE SPASMS (Severe muscle spasms size of walnut knot by the shoulder and injection site), BACK PAIN (Back pain), DYSPNEA (couldn't breath and feels like squeezing) and PAIN (extreme pain) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer and Diabetes.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced MYOCARDIAL INFARCTION (He thought it was an onset of heart attack), MUSCLE SPASMS (Severe muscle spasms size of walnut knot by the shoulder and injection site), BACK PAIN (Back pain), DYSPNEA (couldn't breath and feels like squeezing), PAIN (extreme pain) and FATIGUE (tired). At the time of the report, MYOCARDIAL INFARCTION (He thought it was an onset of heart attack), MUSCLE SPASMS (Severe muscle spasms size of walnut knot by the shoulder and injection site), BACK PAIN (Back pain), DYSPNEA (couldn't breath and feels like squeezing), PAIN (extreme pain) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: follow up received
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: He thought it was an onset of heart attack; Severe muscle spasms size of walnut knot by the shoulder and injection site; Back pain; couldn't breath and feels like squeezing; extreme pain; tired; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (He thought it was an onset of heart attack), MUSCLE SPASMS (Severe muscle spasms size of walnut knot by the shoulder and injection site), BACK PAIN (Back pain), DYSPNEA (couldn't breath and feels like squeezing) and PAIN (extreme pain) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer and Diabetes.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced MYOCARDIAL INFARCTION (He thought it was an onset of heart attack), MUSCLE SPASMS (Severe muscle spasms size of walnut knot by the shoulder and injection site), BACK PAIN (Back pain), DYSPNEA (couldn't breath and feels like squeezing), PAIN (extreme pain) and FATIGUE (tired). At the time of the report, MYOCARDIAL INFARCTION (He thought it was an onset of heart attack), MUSCLE SPASMS (Severe muscle spasms size of walnut knot by the shoulder and injection site), BACK PAIN (Back pain), DYSPNEA (couldn't breath and feels like squeezing), PAIN (extreme pain) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: follow up received
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling cold, Hyperhidrosis, Influenza like illness
Clinical narrative: Felt like Flu; freezing; sweating; weakness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like Flu), FEELING COLD (freezing), HYPERHIDROSIS (sweating) and ASTHENIA (weakness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Felt like Flu), FEELING COLD (freezing), HYPERHIDROSIS (sweating) and ASTHENIA (weakness). At the time of the report, INFLUENZA LIKE ILLNESS (Felt like Flu), FEELING COLD (freezing), HYPERHIDROSIS (sweating) and ASTHENIA (weakness) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No Treatment medications were provided. No Concomitant medications were reported.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: Arm pain; Pain all over my body; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm pain) and MYALGIA (Pain all over my body) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2021321A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PAIN (Arm pain) and MYALGIA (Pain all over my body). At the time of the report, VACCINATION SITE PAIN (Arm pain) and MYALGIA (Pain all over my body) had resolved.            No relevant concomitant medications were reported.   Treatment information was not provided.  On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form." to "On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.", as the dose was not changed.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Action taken changed to not applicable; coding of both events changed; listedness changed accordingly; narrative updated accordingly.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Myalgia
Clinical narrative: arm was sore; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (arm was sore) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced MYALGIA (arm was sore). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 15-Apr-2021, MYALGIA (arm was sore) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 130-180 (abnormal) 130-180.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rash (on stomach) and swelling (bumps) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 046B217) for COVID-19 immunization. No medical history reported. On Apr 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 12, 2021, patient experienced rash (on stomach). On an unknown date, patient experienced swelling (bumps). The patient treated with hydrocortisone for rash, at an unspecified dose and frequency. At the time of the report, rash (on stomach) and swelling (bumps) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Paraesthesia, Paraesthesia oral, Swelling face
Clinical narrative: swelling of the face; tingling face and tongue; tingling in hands and feet,same sensation in her hands and feet; trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swelling of the face), PARAESTHESIA ORAL (tingling face and tongue), PARAESTHESIA (tingling in hands and feet,same sensation in her hands and feet) and DYSPNOEA (trouble breathing) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M204) for COVID-19 vaccination.     Concurrent medical conditions included COPD (since 20 years). Concomitant products included FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY), TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA), IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (COMBIVENT) and SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]) for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced SWELLING FACE (swelling of the face), PARAESTHESIA ORAL (tingling face and tongue), PARAESTHESIA (tingling in hands and feet,same sensation in her hands and feet) and DYSPNOEA (trouble breathing). At the time of the report, SWELLING FACE (swelling of the face), PARAESTHESIA ORAL (tingling face and tongue), PARAESTHESIA (tingling in hands and feet,same sensation in her hands and feet) and DYSPNOEA (trouble breathing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.   This case was linked to MOD-2021-214883 (Patient Link).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 041B21A) for COVID-19 vaccination.     Concomitant products included VALSARTAN and LEVOTHYROXINE for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced DIZZINESS (dizziness). The patient was treated with HYDROCHLOROTHIAZIDE at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness) outcome was unknown. Not Provided
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Myalgia
Clinical narrative: arm soreness not at the injection site, underneath the arm; pain is unbearable with movements/resonating pain when they move the arm; This spontaneous case was reported by a pharmacist and describes the occurrence of AXILLARY PAIN (arm soreness not at the injection site, underneath the arm) and MYALGIA (pain is unbearable with movements/resonating pain when they move the arm) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced AXILLARY PAIN (arm soreness not at the injection site, underneath the arm) and MYALGIA (pain is unbearable with movements/resonating pain when they move the arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. At the time of the report, AXILLARY PAIN (arm soreness not at the injection site, underneath the arm) and MYALGIA (pain is unbearable with movements/resonating pain when they move the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  The pharmacist believes the issue is related to nerve pain.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Chills all night long; Muscle pain on the inside of the legs up to the thighs; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills all night long) and MYALGIA (Muscle pain on the inside of the legs up to the thighs) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Relevant medical history was provided.  Concomitant products included CLOPIDOGREL for an unknown indication.   On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced CHILLS (Chills all night long) and MYALGIA (Muscle pain on the inside of the legs up to the thighs). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CHILLS (Chills all night long) and MYALGIA (Muscle pain on the inside of the legs up to the thighs) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Updated reporter address
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Distractibility, Disturbance in attention, Fatigue, Feeling abnormal
Clinical narrative: confused/ feels befuddled / difficult to focus; head in a fog; loss of peripheral vision; can not drive/start a task and unable to finish it; distracted; pressure at the top of my spine; trouble concentrating/trouble reading my laptop; very tired; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), CONFUSIONAL STATE (confused/ feels befuddled / difficult to focus), FEELING ABNORMAL (head in a fog), VISUAL FIELD DEFECT (loss of peripheral vision) and MOBILITY DECREASED (can not drive/start a task and unable to finish it) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). On 08-Jun-2021, the patient experienced CONFUSIONAL STATE (confused/ feels befuddled / difficult to focus), FEELING ABNORMAL (head in a fog), VISUAL FIELD DEFECT (loss of peripheral vision), MOBILITY DECREASED (can not drive/start a task and unable to finish it), DISTRACTIBILITY (distracted), SPINAL PAIN (pressure at the top of my spine), DISTURBANCE IN ATTENTION (trouble concentrating/trouble reading my laptop) and FATIGUE (very tired). On 08-Jun-2021, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, CONFUSIONAL STATE (confused/ feels befuddled / difficult to focus), FEELING ABNORMAL (head in a fog), VISUAL FIELD DEFECT (loss of peripheral vision), MOBILITY DECREASED (can not drive/start a task and unable to finish it), DISTRACTIBILITY (distracted), SPINAL PAIN (pressure at the top of my spine), DISTURBANCE IN ATTENTION (trouble concentrating/trouble reading my laptop) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant FU - Events outcome updated.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity, Spinal pain, Visual field defect
Clinical narrative: confused/ feels befuddled / difficult to focus; head in a fog; loss of peripheral vision; can not drive/start a task and unable to finish it; distracted; pressure at the top of my spine; trouble concentrating/trouble reading my laptop; very tired; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), CONFUSIONAL STATE (confused/ feels befuddled / difficult to focus), FEELING ABNORMAL (head in a fog), VISUAL FIELD DEFECT (loss of peripheral vision) and MOBILITY DECREASED (can not drive/start a task and unable to finish it) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). On 08-Jun-2021, the patient experienced CONFUSIONAL STATE (confused/ feels befuddled / difficult to focus), FEELING ABNORMAL (head in a fog), VISUAL FIELD DEFECT (loss of peripheral vision), MOBILITY DECREASED (can not drive/start a task and unable to finish it), DISTRACTIBILITY (distracted), SPINAL PAIN (pressure at the top of my spine), DISTURBANCE IN ATTENTION (trouble concentrating/trouble reading my laptop) and FATIGUE (very tired). On 08-Jun-2021, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, CONFUSIONAL STATE (confused/ feels befuddled / difficult to focus), FEELING ABNORMAL (head in a fog), VISUAL FIELD DEFECT (loss of peripheral vision), MOBILITY DECREASED (can not drive/start a task and unable to finish it), DISTRACTIBILITY (distracted), SPINAL PAIN (pressure at the top of my spine), DISTURBANCE IN ATTENTION (trouble concentrating/trouble reading my laptop) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant FU - Events outcome updated.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Feeling abnormal
Clinical narrative: Difficulty breathing/like I can't breath; Still feeling the same inside my body/I feel desperate; Have something in my heart I can't explain; I got very dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (I got very dizzy), DYSPNOEA (Difficulty breathing/like I can't breath), FEELING ABNORMAL (Still feeling the same inside my body/I feel desperate) and CHEST DISCOMFORT (Have something in my heart I can't explain) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included IRON for an unknown indication.    On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced DIZZINESS (I got very dizzy). On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing/like I can't breath), FEELING ABNORMAL (Still feeling the same inside my body/I feel desperate) and CHEST DISCOMFORT (Have something in my heart I can't explain). At the time of the report, DIZZINESS (I got very dizzy), DYSPNOEA (Difficulty breathing/like I can't breath), FEELING ABNORMAL (Still feeling the same inside my body/I feel desperate) and CHEST DISCOMFORT (Have something in my heart I can't explain) had not resolved.            On 03 Jun 2021 patient had done tests on head, blood and urine and results were normal. On 08 Jun 2021 patient visited to primary health care provider and the events related details were unknown to them. Treatment medication was not provided.   This case was linked to MOD-2021-214535 (Patient Link).   Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of myalgia (arm pain) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 040B21A) for COVID-19 immunization. No medical history provided. Concomitant products included iron for an unknown indication. On May 1, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 1, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 1, 2021, patient experienced myalgia (arm pain). Patient treated with oral Tylenol (paracetamol); 1 dosage form. On May 2, 2021, myalgia (arm pain) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or concomitant medications. Treatment included: Tylenol by mouth one time.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 101.7; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101.7) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D24C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure abnormal. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) and ATORVASTATIN for an unknown indication.    On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 101.7). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PYREXIA (fever of 101.7) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jun-2021, Body temperature: 101.7 (High) 101.7 degree.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include blood pressure medication.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Slight sorness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Slight sorness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Slight sorness). On 14-Mar-2021, PAIN IN EXTREMITY (Slight sorness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported    This case was linked to MOD-2021-044324 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Peripheral swelling
Clinical narrative: Swelling in left arm and leg; pain in left knee; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in left arm and leg) and ARTHRALGIA (pain in left knee) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 036A21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN for Blood pressure.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling in left arm and leg) and ARTHRALGIA (pain in left knee). At the time of the report, PERIPHERAL SWELLING (Swelling in left arm and leg) and ARTHRALGIA (pain in left knee) outcome was unknown.            No treatment information provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Pain in extremity, Vaccination site pain
Clinical narrative: Severe arm pain; pain at the injection site, bad pain in my arm where I got the shot; can hardly raise my arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTED LIMB MOBILITY DECREASED (can hardly raise my arm), PAIN IN EXTREMITY (Severe arm pain) and VACCINATION SITE PAIN (pain at the injection site, bad pain in my arm where I got the shot) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (can hardly raise my arm). On an unknown date, the patient experienced PAIN IN EXTREMITY (Severe arm pain) and VACCINATION SITE PAIN (pain at the injection site, bad pain in my arm where I got the shot). At the time of the report, INJECTED LIMB MOBILITY DECREASED (can hardly raise my arm), PAIN IN EXTREMITY (Severe arm pain) and VACCINATION SITE PAIN (pain at the injection site, bad pain in my arm where I got the shot) had not resolved.            Patient is on high blood pressure concomitant medications.  Treatment information was not provided by reporter.   This case was linked to MOD-2021-214538 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-up information received on 28 JUN 2021: contains non-significant information. On 06-Jul-2021: Follow-up information received on 06-JUL-2021: Event and event outcome was updated.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old administered Moderna COVID-19 vaccine (1st dose in the series); This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old administered Moderna COVID-19 vaccine (1st dose in the series)) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hay fever.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old administered Moderna COVID-19 vaccine (1st dose in the series)). On 09-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old administered Moderna COVID-19 vaccine (1st dose in the series)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment information not provided. The reporter reported that the patient was coming on Friday for the second dose.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15 Jul 2021 and does not contain new information.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal dryness, Therapeutic response unexpected
Clinical narrative: side effect as a 'beneficial one; Dry nose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Jun-2021 and was forwarded to Moderna on 09-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NASAL DRYNESS (Dry nose) and THERAPEUTIC RESPONSE UNEXPECTED (side effect as a 'beneficial one) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 20Apr2021) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced NASAL DRYNESS (Dry nose).   On 20-Apr-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (side effect as a 'beneficial one). On 20-Apr-2021, THERAPEUTIC RESPONSE UNEXPECTED (side effect as a 'beneficial one) had resolved. At the time of the report, NASAL DRYNESS (Dry nose) had not resolved.      It is reported that patient were experiencing a symptom of 'overly active nose' or a 'very runny nose' for most of their life. After the first dose of the vaccine, the runny nose symptom was replaced with a dry nose between 18-Mar-2021 to 25-Mar-2021. Afterwards the runny nose symptom was still lessened to a certain extent.   Concomitant product use was not provided by the reporter. No treatment information was provided. After the second dose, the dry nose side effect was immediate and has remained persistent. The patient reported this side effect as a beneficial one.
Sex: U
Vaccine: COVID19
Symptoms: Infertility
Clinical narrative: infertility; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFERTILITY (infertility) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFERTILITY (infertility). At the time of the report, INFERTILITY (infertility) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Hypersensitivity, Neck pain, Pruritus
Clinical narrative: Aggravated neck pain; Coughing; itching at injection site; Pain at the injection site; Chills; Her torso had super itchy; extreme over reaction to mosquito bites; widespread rashes that looked like cellulitis; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Aggravated neck pain), COUGH (Coughing), PRURITUS (Her torso had super itchy), HYPERSENSITIVITY (extreme over reaction to mosquito bites) and RASH (widespread rashes that looked like cellulitis) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cellulitis and Breast cancer in 1998. Concurrent medical conditions included Asthma.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-May-2021, the patient experienced PRURITUS (Her torso had super itchy), HYPERSENSITIVITY (extreme over reaction to mosquito bites) and RASH (widespread rashes that looked like cellulitis). On an unknown date, the patient experienced NECK PAIN (Aggravated neck pain), COUGH (Coughing), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (Chills). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Aggravated neck pain), COUGH (Coughing), PRURITUS (Her torso had super itchy), HYPERSENSITIVITY (extreme over reaction to mosquito bites), RASH (widespread rashes that looked like cellulitis), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    This case was linked to MOD-2021-015278 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Aggravated neck pain; Coughing; itching at injection site; Pain at the injection site; Chills; Her torso had super itchy; extreme over reaction to mosquito bites; widespread rashes that looked like cellulitis; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Aggravated neck pain), COUGH (Coughing), PRURITUS (Her torso had super itchy), HYPERSENSITIVITY (extreme over reaction to mosquito bites) and RASH (widespread rashes that looked like cellulitis) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cellulitis and Breast cancer in 1998. Concurrent medical conditions included Asthma.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-May-2021, the patient experienced PRURITUS (Her torso had super itchy), HYPERSENSITIVITY (extreme over reaction to mosquito bites) and RASH (widespread rashes that looked like cellulitis). On an unknown date, the patient experienced NECK PAIN (Aggravated neck pain), COUGH (Coughing), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (Chills). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Aggravated neck pain), COUGH (Coughing), PRURITUS (Her torso had super itchy), HYPERSENSITIVITY (extreme over reaction to mosquito bites), RASH (widespread rashes that looked like cellulitis), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    This case was linked to MOD-2021-015278 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: More than 42 days elapsed from first vaccine dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 42 days elapsed from first vaccine dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 42 days elapsed from first vaccine dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 42 days elapsed from first vaccine dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not provided.  The treatment information was not provided.  The reporter mentioned that he was fine after the fist dose. As he was going to leave town he was unable to take the second dose of Moderna vaccine. There was an elapse in receiving the second dose that is more than 42 days from the first dose.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient had the first dose on 21apr21 and is showing up today to get the second dose 49 days later; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient had the first dose on 21apr21 and is showing up today to get the second dose 49 days later) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient had the first dose on 21apr21 and is showing up today to get the second dose 49 days later). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient had the first dose on 21apr21 and is showing up today to get the second dose 49 days later) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 31-Mar-2021 and the estimated date of delivery was 12-Jan-2022. On 29-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy.  On 29-Apr-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Date of Last Menstrual Period and Estimated Due Date were added.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Hypersomnia, Pain, Pyrexia
Clinical narrative: Sleeping a lot; body ache; Temperature 102F; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Sleeping a lot), PAIN (body ache) and PYREXIA (Temperature 102F) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced HYPERSOMNIA (Sleeping a lot), PAIN (body ache) and PYREXIA (Temperature 102F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. In May 2021, PYREXIA (Temperature 102F) had resolved. At the time of the report, HYPERSOMNIA (Sleeping a lot) and PAIN (body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102F.         Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: is early in her first trimester of pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (is early in her first trimester of pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (is early in her first trimester of pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (is early in her first trimester of pregnancy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy/ light headed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy/ light headed) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy/ light headed). At the time of the report, DIZZINESS (Dizzy/ light headed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.